Quick Answer
Oncotelic Therapeutics, Inc. reported Total Assets of $26.68 million for fiscal year 2024.
Oncotelic Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $26.68M | -11.1% |
| 2023 | $30.01M | -16.9% |
| 2022 | $36.12M | +53.0% |
| 2021 | $23.61M | -0.2% |
| 2020 | $23.66M | -0.1% |
| 2019 | $23.68M | +762.0% |
| 2018 | $2.75M | +134.5% |
| 2017 | $1.17M | -91.7% |
| 2016 | $14.11M | -48.6% |
| 2015 | $27.45M | -9.8% |
| 2014 | $30.42M | +317.1% |
| 2013 | $7.29M | +33.9% |
| 2012 | $5.45M | -50.7% |
| 2011 | $11.06M | +98.6% |
| 2010 | $5.57M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.16M | +5.1% | +5.5% |
| June 30, 2025 | $26.68M | -10.9% | +0.0% |
| March 31, 2025 | $26.67M | -11.0% | -0.0% |
| December 31, 2024 | $26.68M | -11.1% | -0.4% |
| September 30, 2024 | $26.78M | -11.0% | -10.5% |
| June 30, 2024 | $29.94M | -0.3% | -0.1% |
| March 31, 2024 | $29.97M | -16.8% | -0.1% |
| December 31, 2023 | $30.01M | -16.9% | -0.3% |
- Oncotelic Therapeutics, Inc. showed a decrease of -11.1% in Total Assets compared to the prior fiscal year.
- Over the 2010–2024 period, Oncotelic Therapeutics, Inc.’s total assets has grown by 379.2% (from $5.57 million to $26.68 million).
- The most recent figure is from Oncotelic Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: